Items where Author is "Kalinski, P"

Article

Radomski, M and Zeh, HJ and Edington, HD and Pingpank, JF and Butterfield, LH and Whiteside, TL and Wieckowski, E and Bartlett, DL and Kalinski, P (2016) Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer. Journal for ImmunoTherapy of Cancer, 4 (1).

Muthuswamy, R and Wang, L and Pitteroff, J and Gingrich, JR and Kalinski, P (2015) Combination of IFNα and poly-I: C reprograms bladder cancer microenvironment for enhanced CTL attraction. Journal for ImmunoTherapy of Cancer, 3 (1).

Sinadinos, A and Young, CNJ and Al-Khalidi, R and Teti, A and Kalinski, P and Mohamad, S and Floriot, L and Henry, T and Tozzi, G and Jiang, T and Wurtz, O and Lefebvre, A and Shugay, M and Tong, J and Vaudry, D and Arkle, S and doRego, JC and Górecki, DC (2015) P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy. PLoS Medicine, 12 (10). ISSN 1549-1277

Stroncek, DF and Melief, CJM and Castiello, L and Cesano, A and Cheever, MA and Civini, S and Comin-Anduix, B and Gajewski, TF and Greenberg, PD and Kalinski, P and Kaufman, HL and Kershaw, MH and Khleif, SN and Marincola, F and Merritt, W and Munn, DH and Powell, DJ and Restifo, NP and Rosenberg, SA and Puri, RK and Streicher, H and Szalay, AA and Yee, C and Zitvogel, L and Ribas, A (2013) Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting. Journal for ImmunoTherapy of Cancer, 1.

Obermajer, N and Kalinski, P (2012) Generation of myeloid-derived suppressor cells using prostaglandin E<inf>2</inf>. Transplantation Research, 1 (1).

Fox, BA and Schendel, DJ and Butterfield, LH and Aamdal, S and Allison, JP and Ascierto, PA and Atkins, MB and Bartunkova, J and Bergmann, L and Berinstein, N and Bonorino, CC and Borden, E and Bramson, JL and Britten, CM and Cao, X and Carson, WE and Chang, AE and Characiejus, D and Raja Choudhury, A and Coukos, G and de Gruijl, T and Dillman, RO and Dolstra, H and Dranoff, G and Durrant, LG and Finke, JH and Galon, J and Gollob, JA and Gouttefangeas, C and Grizzi, F and Guida, M and Håkansson, L and Hege, K and Herberman, RB and Stephen Hodi, F and Hoos, A and Huber, C and Hwu, P and Imai, K and Jaffee, EM and Janetzki, S and June, CH and Kalinski, P and Kaufman, HL and Kawakami, K and Kawakami, Y and Keilholtz, U and Khleif, SN and Kiessling, R and Kotlan, B and Kroemer, G and Lapointe, R and Levitsky, HI and Lotze, MT and Maccalli, C and Maio, M and Marschner, JP and Mastrangelo, MJ and Masucci, G and Melero, I and Melief, C and Murphy, WJ and Nelson, B and Nicolini, A and Nishimura, MI and Odunsi, K and Ohashi, PS and O'Donnell-Tormey, J and Old, LJ and Ottensmeier, C and Papamichail, M and Parmiani, G and Pawelec, G and Proietti, E and Qin, S and Rees, R and Ribas, A and Ridolfi, R and Ritter, G and Rivoltini, L and Romero, PJ and Salem, ML and Scheper, RJ and Seliger, B and Sharma, P and Shiku, H and Singh-Jasuja, H and Song, W and Straten, PT and Tahara, H and Tian, Z and van der Burg, SH and von Hoegen, P and Wang, E and Welters, MJP and Winter, H and Withington, T and Wolchok, JD and Xiao, W and Zitvogel, L (2011) Defining the critical hurdles in cancer immunotherapy. Journal of Translational Medicine, 9 (1).

Balwit, JM and Kalinski, P and Sondak, VK and Coulie, PG and Jaffee, EM and Gajewski, TF and Marincola, FM (2011) Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer. Journal of translational medicine, 9. 60 - ?.

John, E and Laskow, TC and Buchser, WJ and Pitt, BR and Basse, PH and Butterfield, LH and Kalinski, P and Lotze, MT (2010) Zinc in innate and adaptive tumor immunity. Journal of Translational Medicine, 8.

Okada, H and Lieberman, FS and Walter, KA and Lunsford, LD and Kondziolka, DS and Bejjani, GK and Hamilton, RL and Torres-Trejo, A and Kalinski, P and Cai, Q and Mabold, JL and Edington, HD and Butterfield, LH and Whiteside, TL and Potter, DM and Schold, SC and Pollack, IF (2007) Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas. Journal of Translational Medicine, 5.